Exagen

About:

Exagen is a patient focused, discovery-driven life science company serving patients affected by autoimmune rheumatic diseases.

Website: https://www.exagen.com

Twitter/X: exageninc

Top Investors: EPIC Ventures, J. Hunt Holdings, Innovatus Capital Partners, Cottonwood Technology Fund, Sun Mountain Capital

Description:

Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE brand, several of which are based on our proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology. Exagen’s goal is to enable providers to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including rheumatoid arthritis and lupus. Exagen was established in 2002 and is headquartered in Vista, California.